Objective To examine hospital variation in cost of childbirth hospitalisations and identify factors that contribute to the variation.
Introduction
Research has shown wide variability in the practice of obstetric care across hospitals. [1] [2] [3] [4] [5] In the USA, there is a ten-fold difference in rate of caesarean delivery and nearly two-fold difference in rate of labour induction among hospitals. 2, 3, 6 Similar variation has been reported in studies from Europe, Oceania and Latin America. 1, 4, 5, 7, 8 This can have important implications for resource use, yet few studies have examined hospital differences in cost of obstetric care and even less is known about the causes of hospital cost variability. Given the high healthcare spending in the USA, 9 substantial costs associated with childbirth care, 10, 11 98.5% of US births occurring within hospitals, 12 and nearly half of births in the USA being financed by Medicaid (state-run public health insurance programmes), 13 a thorough understanding of how and why hospitals differ in cost of childbirth care is important for informing cost containment efforts and insurance reimbursement policies. 14 Furthermore, hospital cost needs to be considered in conjunction with quality and outcomes of care, as lower cost alone may not reflect high-value care. Hospitals may attain low cost through high efficiency in care delivery or by sacrificing quality, where the latter is undesirable. Efforts to reduce resource use should be mindful of potential unintended consequences on quality and patient outcomes. Previous studies have shown mixed findings regarding the relationship between cost and quality among hospitals, 15 but such research has rarely focused on obstetrics. Therefore, assessing whether hospitals with different costs of childbirth have differential birth outcomes is imperative for identifying cost containment opportunities without jeopardising maternal and neonatal health.
To address these important questions, we estimated the cost of childbirth hospitalisations at obstetric hospitals in the State of California using a refined cost-to-charge ratio approach. We assessed magnitude of variation in cost among hospitals and the role of patient case-mix, sociodemographic characteristics, obstetric interventions, type of birth attendant and institutional attributes in explaining cost variation. To inform implications of lower cost for patient outcomes, we also evaluated the association of hospital cost with maternal and newborn morbidity rates. With widespread concerns about rising medical expenditures and interest in promoting high-value care, findings from this study can have broad implications for improving efficiency in obstetric care in the USA as well as other countries.
Methods

Study population
We used linked birth certificate and maternal and newborn hospital discharge data from the State of California, 16 and examined hospitals' 3-year average experience in 2010-12. During this study period, there were a total of 1 490 020 hospitalisations for childbirth from 262 hospitals. Of them, 486 711 were nulliparous term singleton vertex (NTSV) births. We focused on NTSV births to exclude the main risk factors for obstetric care, which helped to isolate cost variation across hospitals due to non-clinical reasons. 17 NTSV births have been widely used in benchmarking hospital performance. 17 We excluded hospitals with fewer than 100 births per year (to focus on routine delivery hospitals and assure stable estimation of hospital performance), 3, 18, 19 Kaiser Permanente hospitals that were not required to provide financial data as a managed care organisation, 20 births with missing or extreme values on hospital cost or maternal/fetal clinical risk factors, and births where the mother or infant was transferred after delivery (as cost of subsequent hospitalisations was not always available) (see Figure S1 ). Our final analytical sample included 405 908 NTSV births from 220 hospitals, reflecting 83.4% of all NTSV births in the state and 84.0% of all delivery hospitals.
Hospital cost
Labour and delivery care affects both the mother and the fetus. Therefore, we considered maternal and newborn hospital stays integral components of a childbirth hospitalisation, and measured combined hospital cost for maternal and newborn care during that hospitalisation (i.e. combined cost of maternal stay for childbirth and the initial newborn stay). Costs of antepartum hospitalisations or readmissions after childbirth were not included. For each mother-infant pair, we measured hospital cost by summing charges for the mother and the newborn from their hospital discharge record and then converting the charges to cost using a refined cost-to-charge ratio (CCR) approach. 21, 22 Hospital-year-specific CCRs, reflecting the cost-to-charge relationship at a given hospital-year, were derived from each hospital's annual cost reports. 21, 23 To more accurately reflect the cost-to-charge relationship in obstetric care, we refined the CCRs by applying an adjustment factor based on the diagnosis-related group of each maternal and newborn hospital stay. 22 By multiplying charges by this refined CCR, we estimated hospital cost of childbirth for each mother-infant pair (see Appendix S1 for more technical details). This cost measure approximated hospital expenses (i.e. resource use) in providing care.
Consistent with previous research, 24 our cost estimate also adjusted for geographic variation in input prices using hospital-year-specific local wage index. Costs from different years were adjusted to 2012 US dollars using the Centers for Medicare and Medicaid Services inpatient hospital market basket index. 25 Costs below 0.5th or above 99.5th percentile were Winsorised to reduce the impact of extreme values.
Birth outcomes
Maternal morbidity was measured by a composite binary indicator (yes/no) for whether the mother experienced inhospital death or any of 21 severe maternal complications such as eclampsia, amniotic fluid embolism and sepsis. 26, 27 This measure of severe maternal morbidity has been used by the US Centers for Disease Control and Prevention to track national trends in maternal outcomes. 27 Newborn morbidity was also measured by a composite binary indicator (yes/no), reflecting whether the infant experienced inhospital death, Apgar score < 3 at 5 or 10 minutes after birth, or any of six categories of severe complications including severe infection, severe respiratory complications, severe birth trauma, severe neurological damage, severe hypoxia/asphyxia and severe shock/resuscitation. 28 This measure of severe newborn morbidity has been endorsed by the US National Quality Forum as a quality indicator for perinatal health. 28 Both metrics have been successfully used in comparing hospital performance, 29, 30 with measurement details published elsewhere. [26] [27] [28] Each of the mortality/morbidity items was determined based on patient's discharge disposition status and International Classification of Diseases ninth revision (ICD-9) diagnosis and procedure codes documented in hospital discharge records and relevant data elements on birth certificates.
Patient, provider and institutional characteristics
To account for differences in patient case-mix across hospitals, we measured 35 maternal and fetal clinical risk factors such as maternal age, hypertensive disorders of pregnancy, fetal anomalies and small-for-gestational-age. These risk factors were intended to capture maternal co-morbid conditions and obstetric indications that were present before the childbirth hospitalisation and did not include complications resulting from care received during the hospitalisation. They were selected based on clinical relevance and evidence from literature regarding factors that influence obstetric care. [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] These conditions were determined based on diagnosis codes and birth certificate data elements (see detailed definition and measurement of these risk factors in the Table S1 ).
Maternal sociodemographic characteristics were measured using information from birth certificate and hospital discharge records and included race, ethnicity, education, primary payer and median household income for zip code. 41 Obstetric interventions included caesarean delivery, induction of labour, epidural/spinal anaesthesia during labour and episiotomy. They were measured based on combined information from birth certificate and ICD-9 procedure codes in hospital discharge records. Type of birth attendant was documented on the birth certificate reflecting category of the principal birth attendant (Doctor of Medicine, Doctor of Osteopathic Medicine, midwife, or other providers).
Measures of institutional characteristics, including teaching/urban-rural status (urban teaching, urban non-teaching or rural), type of ownership (private for-profit, private non-profit or non-federal government), healthcare system affiliation (yes/no) and neonatal care capacity (level I-IV), were obtained from the American Hospital Association annual survey and the California Perinatal Quality Care Collaborative. [42] [43] [44] In addition, for each hospital, we determined its geographic region within the State of California following categorisation by the Regional Perinatal Programs of California (e.g. North Coast-East Bay, Northeastern and Southern Inland Counties), 45 and calculated its average annual delivery volume and level of market competition. A hospital's delivery volume was categorised as small, medium or large using different cut-off values depending on its teaching status and urban-rural location, as recommended by previous research. 46 Market competition was assessed by the Herfindahl-Hirschman index, i.e. sum of the squared market share of each hospital, where market share was defined as the percentage of births in a county delivered at a given hospital.
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Statistical analysis
For each hospital, we calculated its unadjusted cost of childbirth hospitalisations as the mean observed cost among all its NTSV births in the sample. In addition, we calculated risk-standardised cost for each hospital based on a hierarchical generalised linear model that adjusted for patient clinical risk factors and a hospital-specific random intercept. 49 All 35 maternal and fetal clinical risk factors were considered as candidate risk-adjustors and those that were significant at P < 0.20 level were retained in the final model (see Table S2 ). Based on results from this hierarchical generalised linear model model and applying a method similar to the approach used by the Centers for Medicare and Medicaid Services in benchmarking hospital performance on resource use, 50 we calculated a risk-standardised cost for each hospital accounting for its patient case-mix and hospital-specific effect (see Appendix S1, for more technical details).
To examine the role of other factors in explaining hospital variation in cost, we used a method consistent with previous research 51 by adding maternal sociodemographic characteristics, obstetric interventions, type of birth attendant and institutional attributes, respectively (i.e. one subset at a time), to our base model that only adjusted for maternal and fetal clinical risk factors. Comparison of variance in cost between each of these models and our base model informed the relative contribution of these additional factors to overall variation in cost, net of the effect of patient case-mix. With the hierarchical data structure (births clustered within hospitals), each model partitioned the total variance of cost into two components: 'betweenhospital' variance and 'within-hospital' variance. 'Betweenhospital' variance quantifies variability in cost from one hospital to another at the hospital level; whereas 'within-hospital' variance informs variability in cost from one patient to another within the same hospital. 49 A decrease in 'between-hospital' variance indicated that factors added to the model helped to explain differences in cost across hospitals, while a reduction in 'within-hospital' variance suggested that factors added to the model explained variability in cost among patients within the same hospital. Levene's test for equality of variance was used to determine whether change in each of these variance components between two models was statistically significant. To evaluate their collective impact, we estimated one additional model that simultaneously added all these factors to our base model.
To assess birth outcomes, we also estimated risk-standardised rates of severe maternal morbidities and severe newborn morbidities, respectively, for each hospital using methods analogous to the calculation of risk-standardised cost (see Appendix S1, for more details). Association between hospital risk-standardised cost and risk-standardised severe morbidity rates was evaluated using Pearson correlation coefficient. As a sensitivity analysis, we estimated risk-standardised cost of maternal care and riskstandardised cost of newborn care separately as well, and examined their correlation with risk-standardised rate of severe maternal morbidities and severe newborn morbidities, respectively. This also allowed us to assess the correlation between risk-standardised maternal cost and riskstandardised newborn cost to inform whether hospitals with high maternal cost also had high newborn cost.
Results
Sample characteristics
Of the 405 908 NTSV births in our sample, median maternal age was 25 years (interquartile range 20-30) ( Table 1) . Seven percent of the mothers had diabetes or abnormal glucose tolerance, 8.5% had hypertensive disorders and 14.8% were morbidly obese or obese. Three percent of the births had a fetal anomaly and 11.9% were small-for-gestational-age.
Most mothers (73.5%) were white, 47.2% were Hispanic, and 49.5% had Medicaid insurance (see Table S3 ). Consistent with previous research, 52 only approximately 2% of the NTSV births were delivered at rural hospitals, while 37.2% occurred at urban teaching hospitals. Most deliveries (68.2%) were at private non-profit hospitals.
Among these NTSV births, median unadjusted cost of a hospitalisation was $5,933 (10th-90th percentile range: $3,361-$11,738) (data not shown). Most of this cost was accounted for by maternal care, which averaged 80.0% (as opposed to newborn care).
Hospital-level variation in cost
At the hospital level, unadjusted cost of childbirth hospitalisations varied across the 220 hospitals in our sample, with a median of $6,750 and 10th-90th percentile range of $4,353-$10,229 (Figure 1 ). Even after adjusting for patient clinical risk factors, risk-standardised cost varied from $4,760 in hospitals at the 10th percentile to $10,644 in hospitals at the 90th percentile (Figure 1 ). The magnitude of these variations is substantial based on conventional thresholds for coefficient of variation. 53 Sensitivity analysis assessing cost of maternal and newborn care separately also showed large variation across hospitals (see Figure S2) . Risk-standardised costs of maternal care and newborn care were moderately correlated (correlation coefficient 0.45, P < 0.001), 54 suggesting that hospitals with high maternal cost tended to have high newborn cost as well.
Factors contributing to hospital variation in cost Table 2 summarises changes in between-hospital and within-hospital variance in cost after further adjusting for other patient, intervention, provider and institutional characteristics. In our base model where only maternal and fetal clinical risk factors were adjusted for, between-hospital and within-hospital variances were 0.093 and 0.218, respectively, suggesting that 29.9% (i.e. 0.093/(0.093+0.218)) of the total variance in cost was due to differences across hospitals, as opposed to variability across patients within a hospital. This indicates a large effect of hospitals based on traditional standards. 55 Further adjustment for maternal sociodemographic characteristics, obstetric interventions and type of birth attendant, respectively, did not explain between-hospital variance in cost (Table 2 ). In contrast, controlling for institutional characteristics reduced between-hospital variance by 30.3% (P = 0.002). Among the institutional characteristics assessed, type of ownership, teaching/urban-rural status, neonatal care capacity, and geographic region were most influential. Adjusting for each of these factors individually reduced between-hospital variance by 5.0%, 6.9%, 10.9% and 12.9%, respectively (data not shown). Comparison of hospital risk-standardised cost by these characteristics also showed significant differences (P ≤ 0.002 for all) (see Figure S3) .
Although obstetric interventions did not affect betweenhospital variance in cost, adjustment for these factors considerably reduced within-hospital variance among patients by 15.8% (P < 0.001) ( Table 2 ). Closer examination of models that adjusted for each intervention individually showed that caesarean delivery was most impactful, reducing 14.4% of within-hospital variance, whereas other interventions had little impact (data not shown). Adjustment for maternal sociodemographic characteristics and type of birth attendant did not affect within-hospital variance in cost.
Collectively these sociodemographic, intervention, birth attendant and institutional factors explained 30.7% of the between-hospital variance in risk-standardised cost (P = 0.001) ( Table 2 ). However, substantial variability in cost remained, with the fully adjusted cost still differing significantly between hospitals in the bottom and top quartile (median $5,131 versus $8,987, P < 0.001; data not shown).
Association of hospital cost with birth outcomes
There was no association between a hospital's risk-standardised cost and risk-standardised rate of severe maternal morbidities (correlation coefficient 0.003, P = 0.97) (Figure 2 ). However, risk-standardised cost was positively correlated with risk-standardised rate of severe newborn morbidities (correlation coefficient 0.22, P = 0.001) (Figure 2 ). Sensitivity analysis examining risk-standardised cost of maternal and newborn care separately also showed no cost-outcome relationship in maternal care, but revealed a strong correlation between cost of newborn care and rate of severe newborn morbidities (correlation coefficient 0.55, P < 0.001) (see Figure S4 ). 54 
Discussion
Main findings
We found notable differences in cost of childbirth across 220 hospitals in California even after accounting for differences in patient case-mix. However, hospitals with higher Statistics reported as n and % unless otherwise specified. IQR, interquartile range.
cost did not have better birth outcomes. Several institutional characteristics were identified as important factors contributing to between-hospital variation in cost.
Strengths and limitations
Our study extended the current literature in two important ways. First, we evaluated hospital cost in conjunction with birth outcomes to inform value in obstetric care. Our results showed that on average, higher-cost hospitals did not achieve lower rates of maternal or newborn morbidities. This is consistent with findings from other studies in the USA and European countries showing no benefit of excessive obstetric interventions (e.g. caesarean delivery) in improving maternal or perinatal outcomes. 2, 5, 56, 57 The American College of Obstetricians and Gynecologists also highlighted 'limited or uncertain benefit' of many common obstetric practices (e.g. continuous electronic fetal heartrate monitoring) and called for efforts to reduce their use. 58 Hence, there is potential to decrease cost of childbirth care at high-cost institutions without compromising patient outcomes. Close examination of experience at highvalue hospitals (i.e. those achieving low cost and low morbidity rates) may reveal successful practices to help enhance efficiency at other hospitals. Further research identifying cost components that differed the most between high-value and low-value hospitals can also provide useful insights. Meanwhile, innovative payment and delivery models such as episode-based payment, fee-for-value programmes and public reporting may help to incentivise provision of efficient care 59 and steer patients to high-value institutions.
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Second, we identified several factors that contributed to a considerable proportion of hospital variation in cost, including hospital type of ownership, teaching/urban-rural status, neonatal care capacity and geographic region. This finding is consistent with previous evidence that type of ownership helped to explain hospital variation in costs or charges of maternity stay 19, 20 and presence of a separate neonatology unit contributed to hospital differences in cost of obstetric hospitalisations.
14 These institutional characteristics help to inform future targeted efforts in cost containment and highlight areas for additional research. Hospitals with these different attributes may have different financial incentives, organisation and delivery of care, or staffing that influence resource use. For example, hospitals with different types of ownership have been shown to differ in nursing skill mix and hours. 63, 64 The underlying mechanisms of cost difference between these types of hospitals warrant further investigation.
Nevertheless, we recognise several limitations of our study. Without detailed medical record data, there may be unmeasured clinical factors confounding our observed hospital variation in cost. Therefore, despite our use of an extensive data set and a relatively homogeneous NTSV population, there remains a possibility of residual differences in patient case-mix across hospitals after our risk adjustment. Moreover, hospitals may have different accounting practices in allocating shared cost items across service lines, 14 which may also confound our estimated differences in cost across hospitals. Nonetheless, our analysis should be able to capture major differences in resource use across institutions and inform discussion about cost containment in obstetrics. Additionally, we only have measures on type of birth attendant. Further research is needed to more thoroughly evaluate potential contributions of provider-related factors to cost variation (e.g. experience, subspecialty training) given their important role in prescribing care. Likewise, our assessment of institutional characteristics was limited to conventional measures that were readily available. Additional efforts to ascertain and assess other hospital attributes may help to identify reasons for the remaining unexplained variance in cost. Finally, our data came from a single state within the USA. Future studies of hospitals in other areas of the USA NA, not applicable. *P value based on Levene's test for equality of variance between current model and the base model. **Maternal sociodemographic characteristics included race, ethnicity, education, primary payer and median household income for zip code. ***Obstetric interventions included caesarean delivery, induction of labour, epidural/spinal anaesthesia during labour and episiotomy. ****Institutional characteristics included teaching/urban-rural status, type of ownership, affiliation with a healthcare system, annual delivery volume, level of neonatal care capacity, geographic region and market competition. For rural, urban non-teaching and urban teaching hospitals, their volume was categorised as small if they delivered ≤ 200, ≤ 650 and ≤ 1700 births per year, respectively; medium if they delivered 201-400, 651-1400, and 1701-3000 births per year, respectively; and large if they delivered > 400, > 1400, and > 3000 births per year, respectively. Market competition was categorised as unconcentrated (Herfindahl-Hirschman index (HHI) < 1500), moderately concentrated (1500 ≤ HHI ≤ 2500), or highly concentrated (HHI > 2500). *****Include all maternal sociodemographic characteristics, obstetric interventions, type of birth attendant and institutional characteristics described above.
and other countries will inform the generalisability of our findings.
Interpretation
We found a positive correlation between risk-standardised cost and severe newborn morbidity rate, which is contrary to the conventional belief that more expensive hospitals would have better quality and outcomes of care. Indeed, two competing mechanisms can influence the relationship between hospital resource utilisation and patient outcomes: hospitals may invest in quality enhancement activities (hence incur higher costs) to help prevent morbidities; whereas, poor maternal or newborn outcomes can necessitate further care and so additional cost. Newborn complications may have a stronger financial impact than maternal complications, resulting in the positive cost-morbidity Figure 2 . Relationship of risk-standardised cost with risk-standardised rates of severe maternal morbidities and severe newborn morbidities among hospitals (n = 220 hospitals, each dot reflects one hospital).
relationship observed in newborn care (but not in maternal care). In our sample, median cost of a childbirth hospitalisation was $12,328 higher among NTSV births with severe newborn morbidities than those without, but $4,187 higher among NTSV births with severe maternal morbidities than those without. Although caesarean delivery can substantially influence cost, its role in explaining variation in cost across hospitals has not been evaluated previously. Our study showed that variable use of caesarean delivery only contributed to difference in cost at the patient level but did not explain differences in cost between hospitals. This is likely due to a lack of systematic relationship between caesarean rates and cost of care at the hospital level. Hospitals may differ in how and why they use caesarean delivery. Depending on the circumstances of use (e.g. whether used for appropriate indications or at the right timing), hospitals with similar caesarean rates may have higher or lower cost, leading to no methodical relationship between its utilisation rate and cost at the hospital level. This is partly supported by the lack of consistent evidence in literature regarding reasons for the variable use of caesarean delivery among hospitals. 2, 3, 65 Additional research is needed to validate our findings and identify potential inappropriate use of this costly intervention.
Conclusion
There was large variation in cost of childbirth across hospitals, and hospitals with higher cost did not have better outcomes after accounting for differences in patient case-mix. Further research to examine underlying mechanisms of the cost variation will help to promote value and efficiency in obstetric care in the long run. This may include research to compare practice patterns at hospitals with different types of ownership, teaching/urban-rural status, neonatal care capacity, and geographic location. Moreover, research to evaluate other hospital and provider characteristics that may contribute to cost variation in peripartum care and to identify cost components that differ the most between high-value and low-value hospitals would provide additional insights.
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